ANDA 78769, held by Actavis Elizabeth. Ibuprofen; Oxycodone Hydrochloride.
As of Nov 16, 2026, ANDA 78769 (Oxycodone Hydrochloride And Ibuprofen), held by Actavis Elizabeth, was first approved by FDA on Jan 4, 2008, with 18 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 4, 2008 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Oxycodone Hydrochloride And Ibuprofen400MG;5MG · tablet;oral | Ibuprofen; Oxycodone Hydrochloride | Discontinued |
| Jun 18, 2026 | Supplement 40REMS | Approved | None posted |
| Dec 23, 2025 | Supplement 38Labeling · Standard review | Approved | None posted |
| Nov 21, 2024 | Supplement 37Labeling · Standard review | Approved | None posted |
| Oct 31, 2024 | Supplement 36REMS | Approved | None posted |
| Mar 27, 2024 | Supplement 35Labeling · Standard review | Approved | None posted |
| Mar 27, 2024 | Supplement 34Labeling · Standard review | Approved | None posted |
| Dec 15, 2023 | Supplement 33Labeling · Standard review | Approved | None posted |
| Apr 28, 2021 | Supplement 32Labeling · Standard review | Approved | None posted |
| Mar 4, 2021 | Supplement 31Labeling · Standard review | Approved | None posted |
| Oct 8, 2019 | Supplement 25Labeling · Standard review | Approved | None posted |
| Jul 22, 2019 | Supplement 24Labeling · Standard review | Approved | None posted |
| Sep 21, 2018 | Supplement 23Labeling · Standard review | Approved | None posted |
| Sep 18, 2018 | Supplement 22REMS | Approved | None posted |
| Aug 15, 2018 | Supplement 20Labeling · Standard review | Approved | None posted |
| Dec 16, 2016 | Supplement 18Labeling · Standard review | Approved | None posted |
| Dec 16, 2016 | Supplement 16Labeling · Standard review | Approved | None posted |
| Dec 16, 2016 | Supplement 15Labeling · Standard review | Approved | None posted |
| Sep 2, 2011 | Supplement 8Labeling | Approved | None posted |
| Jan 4, 2008 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters